Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Khasraw

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Scientific Reports|October 23, 2025
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8<sup>+</sup> infiltration in gliomaKirit Singh, Matthew W Foster, Marlene J Violette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Neuro-Oncology|October 6, 2025
Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology CollaborativeAkanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, et al.
Nature Medicine|July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue samplingKirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Nature Medicine|February 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastomaGeorgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Cancer Immunology Research|April 4, 2024
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer ImmunotherapyMichael V Martin, Salvador Aguilar-Rosas, Katka Franke, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Scientific Reports|October 23, 2025
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8<sup>+</sup> infiltration in gliomaKirit Singh, Matthew W Foster, Marlene J Violette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Neuro-Oncology|October 6, 2025
Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology CollaborativeAkanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, et al.
Nature Medicine|July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue samplingKirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Nature Medicine|February 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastomaGeorgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Cancer Immunology Research|April 4, 2024
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer ImmunotherapyMichael V Martin, Salvador Aguilar-Rosas, Katka Franke, et al.
Pageof 18